SCFAs strongly stimulate PYY production in human enteroendocrine cells

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Larraufie, P ^a   Martin Gallausiaux, C ^b,c   Lapaque, N ^b   Dore, J ^b   Gribble, F M ^a   Reimann, F ^a   Blottiere, H M ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; PEPTIDE YY; VOLATILE FATTY ACID;

CELL CULTURE; CELL LINE; DRUG EFFECT; ENTEROENDOCRINE CELL; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM;

CELL LINE; CELLS, CULTURED; ENTEROENDOCRINE CELLS; FATTY ACIDS, VOLATILE; GENE EXPRESSION; GLUCAGON-LIKE PEPTIDE 1; HUMANS; PEPTIDE YY;

EID: 85042757297     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-18259-0     Document Type: Article

References (42)

1. Boey, D. et al. Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia 49, 1360-70 (2006).
2. Kreymann, B., Williams, G., Ghatei, M. A. & Bloom, S. R. Glucagon-like peptide-1 7-36: A physiological incretin in man. Lancet (London, England) 2, 1300-4 (1987).
3. Zanchi, D. et al. The impact of gut hormones on the neural circuit of appetite and satiety: A systematic review. Neurosci. Biobehav. Rev. 80, 457-475 (2017).
4. Svane, M. S. et al. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery. Int. J. Obes. (Lond). 40, 1699-1706 (2016).
5. Guida, C., Stephen, S., Guitton, R. & Ramracheya, R. D. The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes. Trends Endocrinol. Metab., https://doi.org/10.1016/j.tem.2017.04.005 (2017).
6. Steinert, R. E. et al. Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB. Physiol. Rev. 97 (2016).
7. Habib, A. M., Richards, P., Rogers, G. J., Reimann, F. & Gribble, F. M. Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells. Diabetologia, https://doi.org/10.1007/s00125-013-2887-z (2013).
8. Ezcurra, M., Reimann, F., Gribble, F. M. & Emery, E. Molecular mechanisms of incretin hormone secretion. Curr. Opin. Pharmacol. 13, 922-7 (2013).
9. Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P. & Macfarlane, G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221-7 (1987).
10. Brown, A. J. et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312-9 (2003).
11. Le Poul, E. et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278, 25481-9 (2003).
12. Thangaraju, M. et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69, 2826-32 (2009).
13. Candido, E. P., Reeves, R. & Davie, J. R. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14, 105-13 (1978).
14. Schmidt, J. et al. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. J. Biol. Chem. 286, 10628-40 (2011).
15. Hudson, B. D., Tikhonova, I. G., Pandey, S. K., Ulven, T. & Milligan, G. Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3. J. Biol. Chem. 287, 41195-209 (2012).
16. Davie, J. R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133, 2485S-2493S (2003).
17. Thakur, B. K., Dasgupta, N., Ta, A. & Das, S. Physiological TLR5 expression in the intestine is regulated by differential DNA binding of Sp1/Sp3 through simultaneous Sp1 dephosphorylation and Sp3 phosphorylation by two different PKC isoforms. Nucleic Acids Res. 44, 5658-72 (2016).
18. Aoyama, M., Kotani, J. & Usami, M. Butyrate and propionate induced activated or non-Activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition 26, 653-61 (2010).
19. Cherbut, C. et al. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol Gastrointest Liver Physiol 275, G1415-1422 (1998).
20. Samuel, B. S. et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-Acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. USA 105, 16767-72 (2008).
21. Delzenne, N. M., Cani, P. D., Daubioul, C. & Neyrinck, A. M. Impact of inulin and oligofructose on gastrointestinal peptides. Br. J. Nutr. 93(Suppl 1), S157-61 (2005).
22. Tolhurst, G. et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364-71 (2012).
23. Psichas, A. et al. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int. J. Obes. 39, 424-9 (2015).
24. Forbes, S. et al. Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models. Diabetes 64, 3763-3771 (2015).
25. Cani, P. D., Hoste, S., Guiot, Y. & Delzenne, N. M. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br. J. Nutr. 98, 32-7 (2007).
26. Petersen, N. et al. Generation of L cells in mouse and human small intestine organoids. Diabetes 63, 410-20 (2014).
27. Brooks, L. et al. Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety. Mol. Metab. 6, 48-60 (2017).
28. Zhou, J. et al. Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity (Silver Spring). 14, 683-9 (2006).
29. Chambers, E. S. et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64, 1744-54 (2015).
30. Tazoe, H. et al. Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed. Res. 30, 149-56 (2009).
31. Reimer, R. A. A Human Cellular Model for Studying the Regulation of Glucagon-Like Peptide-1 Secretion. Endocrinology 142, 4522-4528 (2001).
32. Rozengurt, N. et al. Colocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colon. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G792-802 (2006).
33. Bolognini, D. et al. A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias. J. Biol. Chem. 291, 18915-31 (2016).
34. Gallinari, P., Marco, S., Jones, P., Pallaoro, M. & Steinkühler, C. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res. 17, 195 (2007).
35. Dokmanovic, M., Clarke, C. & Marks, P. A. Histone Deacetylase Inhibitors: Overview and Perspectives. Mol. Cancer Res. 5, 981-989 (2007).
36. Reimann, F. et al. Glucose sensing in L cells: A primary cell study. Cell Metab. 8, 532-9 (2008).
37. Lin, M. Y., de Zoete, M. R., van Putten, J. P. M. & Strijbis, K. Redirection of Epithelial Immune Responses by Short-Chain Fatty Acids through Inhibition of Histone Deacetylases. Front. Immunol. 6, 554 (2015).
38. Larraufie, P., Doré, J., Lapaque, N. & Blottière, H. M. TLR Ligands and Butyrate Increase Pyy Expression through Two Distinct but Inter-regulated Pathways. Cell. Microbiol, https://doi.org/10.1111/cmi.12648 (2016).
39. Parnell, J. A. & Reimer, R. A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 89, 1751-9 (2009).
40. Cani, P. D. et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 90, 1236-43 (2009).
41. Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-6 (2013).
42. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-23 (2013).